Medications are an underappreciated but well-documented cause of swollen lymph nodes. Dozens of drug classes, from common seizure medications to cutting-edge cancer immunotherapies, can trigger lymph node enlargement through several distinct mechanisms. The swelling sometimes looks so much like lymphoma on imaging and even under a microscope that pathologists have developed specific criteria to tell the two apart. Understanding which drugs do this, how, and when the swelling should raise concern matters for anyone who discovers a new lump while taking a medication.
How Drugs Trigger Lymph Node Swelling
The most dramatic drug-related cause of swollen lymph nodes is a condition called drug-induced hypersensitivity syndrome, also known as drug reaction with eosinophilia and systemic symptoms (DRESS). This is an immune overreaction where the body’s T cells and macrophages become activated against a medication and release a flood of inflammatory signals. It typically shows up two to eight weeks after starting a new drug and brings fever, widespread rash, organ damage, and enlarged lymph nodes throughout the body.1PubMed Central. Drug-Induced Hypersensitivity Syndrome: A Clinical, Radiologic, and Histologic Mimic of Lymphoma The skin is the organ most often affected, but the lymph node swelling can be the most alarming feature because it raises the obvious question: is this cancer?2Archives of Pathology and Laboratory Medicine. Morphologic Spectrum of Lymphadenopathy in Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome A Case Series With Literature Review
Beyond DRESS, there are other pathways. Serum sickness-like reactions, most often seen with antibiotics, monoclonal antibodies, and vaccines, involve immune complex formation that can cause joint pain, skin changes, and lymph node swelling. These are more common in children and tend to be self-limiting, though the underlying immune mechanisms are still not fully understood.3PubMed Central. Serum Sickness-Like Reaction: A Narrative Review of Epidemiology, Immunopathogenesis, Diagnostic Challenges, and Therapeutic Approaches And some drugs, particularly immunosuppressants used for autoimmune diseases, can cause lymph nodes to enlarge through a fundamentally different process: promoting uncontrolled growth of immune cells in a way that blurs the line between a drug reaction and an actual blood cancer.
Which Drugs Are Most Often Responsible
Antiepileptic drugs have the longest track record here. Phenytoin, one of the oldest and most widely used seizure medications, has been linked to lymph node enlargement since the mid-20th century. It can produce a condition called pseudolymphoma syndrome, where lymph nodes swell with abnormal-looking immune cells that closely resemble a real lymphoma. Other seizure drugs in the same family, including carbamazepine and phenobarbital, can do the same thing.4Seizure. Granulomatous lymphadenopathy secondary to phenytoin therapy In published cases, this pseudolymphoma has occasionally been fatal when it was accompanied by severe liver inflammation or dangerously low white blood cell counts.
Anticonvulsants are far from the only culprits. The broader list includes:
- Antibiotics: Certain sulfonamides and beta-lactams can trigger serum sickness-like reactions or DRESS with lymphadenopathy.
- Allopurinol: Used for gout, this is one of the more common causes of DRESS worldwide.
- Antidepressants: Some have been implicated in pseudolymphoma.5PubMed Central. Phenytoin Induced Cutaneous B Cell Pseudolymphoma
- Dapsone: An antibiotic used for certain skin conditions, which can produce its own hypersensitivity syndrome with fever, rash, and cervical lymph node swelling weeks after starting therapy.
- ACE inhibitors: Blood pressure medications that have occasionally been linked to pseudolymphoma-type reactions.
Even ethosuximide, a seizure drug more commonly associated with milder side effects, has been reported to cause DRESS with swollen lymph nodes not only in the neck and armpits but also deep inside the chest. Hilar and mediastinal lymphadenopathy, the kind visible only on a CT scan, may be underreported in DRESS because chest imaging is not always performed.6PubMed. Ethosuximide-induced drug reaction with eosinophilia and systemic symptoms with mediastinal lymphadenopathy
Cancer Immunotherapy and Sarcoidosis-Like Reactions
A newer and increasingly recognized scenario involves immune checkpoint inhibitors, the blockbuster cancer drugs that work by unleashing the immune system against tumors. Drugs like pembrolizumab and ipilimumab, used for melanoma, lung cancer, and other malignancies, can cause the immune system to overshoot its target and create clusters of inflammatory cells called granulomas inside lymph nodes. The result is a sarcoidosis-like reaction, so named because it resembles the chronic inflammatory disease sarcoidosis, complete with swollen lymph nodes that light up on PET scans exactly the way cancer would.7PubMed Central. Sarcoidosis-like reaction induced by immune checkpoint inhibitor in a patient with hepatocellular carcinoma: a case report
This creates an obvious clinical headache. A cancer patient on immunotherapy who develops new swollen lymph nodes could be experiencing disease progression, a treatment side effect, or both. In one report, three melanoma patients treated with ipilimumab or pembrolizumab developed lymphadenopathy that was initially suspected to be cancer spread but turned out to be sarcoidosis-like inflammation on biopsy.8PubMed. Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitors In another case, a 77-year-old woman on pembrolizumab for uterine cancer developed new lung nodules that looked like metastatic disease on imaging; surgical removal of the nodules revealed non-cancerous granulomas with no evidence of tumor whatsoever.9PubMed Central. Immune Checkpoint Inhibitor-Induced Sarcoidosis-Like Reaction Mimicking Pulmonary Metastasis: A Case Report Getting this wrong would mean either stopping an effective cancer treatment prematurely or subjecting a patient to unnecessary chemotherapy for a benign condition.
Methotrexate and the Blurry Line with True Lymphoma
Methotrexate, a cornerstone drug for rheumatoid arthritis, psoriasis, and other autoimmune conditions, occupies a unique and somewhat unsettling place in this discussion. Long-term use can lead to lymphoproliferative disorders, meaning the drug promotes an actual overgrowth of lymphocytes that causes lymph node swelling. These are classified as methotrexate-associated lymphoproliferative disorders (MTX-LPD), and they sit in an uncomfortable gray zone between a drug side effect and a genuine blood cancer.10JMA Journal. Methotrexate-associated Hodgkin Lymphoma Occurring Decades after Methotrexate Initiation
The reassuring part is that in many cases, simply stopping methotrexate causes the lymph node swelling to go away on its own. In a series of patients with autoimmune diseases who developed lymphadenopathy on methotrexate, the swelling regressed spontaneously after the drug was discontinued in all cases, though one patient later relapsed.11PubMed. Methotrexate-associated lymphoproliferative disorders mimicking angioimmunoblastic T-cell lymphoma The less reassuring part is that some of these cases progress to bona fide Hodgkin or non-Hodgkin lymphoma that requires chemotherapy. One published case involved a man who had been on methotrexate for four decades before developing what turned out to be actual Hodgkin lymphoma. The connection between the drug and the cancer remains an active area of research, with Epstein-Barr virus reactivation under immunosuppression thought to play a role.
Why Herpesvirus Reactivation Matters
One of the more fascinating pieces of this puzzle is the role of dormant viruses. Most adults carry human herpesvirus 6 (HHV-6), Epstein-Barr virus, and cytomegalovirus in a latent state, kept in check by normal immune surveillance. When a drug triggers DRESS, the resulting immune disruption can allow these viruses to wake up, and the viral reactivation itself then amplifies the lymph node swelling and organ damage.
Across pooled data from published studies, HHV-6 reactivation occurred in about 63% of DRESS patients, significantly more often than any other herpesvirus. That reactivation was tied to worse outcomes and greater severity.12PubMed Central. Immunopathogenic Insights on Preferential Human Herpesvirus-6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms: A Scoping Review In at least one case, researchers found direct evidence of HHV-6 actively replicating inside the tissue of a surgically removed lymph node from a DRESS patient, confirming that the virus is not just a bystander but an active contributor to the swelling.13PubMed Central. Evidence for reactivation of human herpesvirus 6 in generalized lymphadenopathy in a patient with drug-induced hypersensitivity syndrome Other herpesviruses, including HHV-7, cytomegalovirus, and Epstein-Barr virus, can also reactivate during these drug reactions, adding layers of complexity.14PubMed. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome
This means that what starts as a reaction to a medication can become a three-way interaction among the drug, the immune system, and reactivated viruses, each driving the others and making the lymphadenopathy more pronounced and harder to resolve.
Vaccines and Lymph Node Swelling
Strictly speaking, vaccines are not drugs in the traditional pharmacological sense, but they are administered substances that reliably cause lymph node swelling, and many people encounter this situation during routine medical care. The COVID-19 mRNA vaccines made this phenomenon highly visible. Swollen lymph nodes in the armpit on the same side as the injection became a well-recognized side effect, sometimes appearing within days and lasting for weeks.15PubMed Central. Axillary Lymph Node Swelling After COVID-19 Booster Vaccination: Japanese Case Report and Literature Review
For most people this was a nuisance at worst, but it created genuine diagnostic confusion for breast cancer screening. Women who received a vaccine in one arm and then had a mammogram could show up with swollen axillary lymph nodes that looked suspicious for metastatic disease. Radiologists quickly learned to ask about recent vaccination history, but the issue persisted. In some cases, the lymphadenopathy showed up only on imaging, without the patient noticing anything. Published case reviews found a range of pathological findings when these nodes were biopsied, with most showing simple reactive changes, though rarer patterns including Kikuchi-Fujimoto disease and even Rosai-Dorfman disease were occasionally seen.16PubMed Central. COVID-19 vaccine-associated lymphadenopathy: a review
The duration varied considerably. In one documented case, a swollen axillary lymph node appeared seven days after a first COVID-19 vaccination and persisted, though gradually improving, for six months.17PubMed Central. Timing and Duration of Axillary Lymph Node Swelling After COVID-19 Vaccination: Japanese Case Report and Literature Review That is much longer than most people expect from a side effect, and it understandably caused anxiety. For this reason, some medical organizations suggested scheduling mammograms either before vaccination or at least four to six weeks afterward to reduce false alarms.
Why Drug-Related Lymphadenopathy Mimics Lymphoma
The reason drug-induced lymph node swelling causes so much diagnostic anxiety is not just that the nodes get big. Under a microscope, the cellular changes can look remarkably like cancer. Pathologists have described at least four distinct patterns of lymph node changes in DRESS: reactive lymphoid hyperplasia (an exaggerated but normal-looking immune response), necrotizing lymphadenitis (lymph node tissue destruction), a pattern that resembles Hodgkin lymphoma, and a pattern that mimics a specific aggressive T-cell lymphoma called angioimmunoblastic T-cell lymphoma. The last two are the troubling ones, because they can lead directly to a misdiagnosis of cancer and unnecessary chemotherapy.2Archives of Pathology and Laboratory Medicine. Morphologic Spectrum of Lymphadenopathy in Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome A Case Series With Literature Review
Drug-induced pseudolymphoma adds another layer. The term covers a group of benign immune cell overgrowths that simulate lymphoma either in how they appear on the skin or in what they look like under a microscope. Correctly identifying these as drug reactions rather than cancers depends on correlating the biopsy findings with the patient’s medication history and watching what happens when the drug is stopped. A patient on phenytoin who develops swollen lymph nodes needs careful evaluation to distinguish a drug-induced pseudolymphoma from a genuine malignancy, because the treatment paths diverge radically: one requires stopping a pill, the other requires chemotherapy.18PubMed. Phenytoin-induced lymphadenopathy
Genetic Susceptibility
Not everyone on a given medication develops DRESS or pseudolymphoma. The difference often comes down to genetics, specifically variations in the human leukocyte antigen (HLA) system, the set of genes that shapes how your immune system recognizes foreign substances. For certain drugs, strong associations exist between specific HLA types and the risk of hypersensitivity. The clearest example is abacavir, an HIV medication, where carrying a specific genetic variant (HLA-B*5701) dramatically increases the risk of a severe hypersensitivity reaction. Similar associations have been found for carbamazepine and allopurinol.19PubMed Central. Genetic factors in the predisposition to drug-induced hypersensitivity reactions
For abacavir, this discovery translated directly into clinical practice. Patients are now routinely tested for HLA-B*5701 before starting the drug, and those who carry it are given an alternative. This kind of pre-prescription genetic screening has dramatically reduced the incidence of abacavir hypersensitivity. For most other drugs associated with lymphadenopathy, though, genetic testing is not yet standard, partly because the associations are less absolute and partly because the reactions are rarer. The field of pharmacogenomics is working to change this, but for now, most drug-induced lymphadenopathy is discovered the old-fashioned way: a patient notices something swollen and a clinician works backward to the medication list.
What to Do If You Notice Swollen Lymph Nodes on a Medication
The practical question is straightforward: if you feel a new lump in your neck, armpit, or groin while taking a medication, should you worry? The honest answer is that you should mention it to your doctor promptly, but you should not assume the worst. Drug-induced lymphadenopathy is far less common than the everyday lymph node swelling caused by a cold or minor infection, but it is well-documented enough that any clinician evaluating new lymphadenopathy should be asking about your medication history.
The timing offers a useful clue. DRESS typically appears two to eight weeks after starting a new drug, so lymph node swelling that shows up in that window, especially alongside a rash, fever, or abnormal blood tests, should raise the possibility of a drug reaction.1PubMed Central. Drug-Induced Hypersensitivity Syndrome: A Clinical, Radiologic, and Histologic Mimic of Lymphoma Methotrexate-related lymphoproliferative disorders, by contrast, can develop years or even decades into treatment. And vaccine-related swelling tends to appear within the first two weeks after an injection, on the same side of the body.
When drug-induced lymphadenopathy is suspected, the most important diagnostic step is often the simplest: stopping the suspected medication and seeing if the swelling resolves. In many cases it does, sometimes within weeks. If the nodes do not shrink, or if they continue to grow, a biopsy becomes necessary to rule out a true malignancy. The key point for pathologists is that the clinical context, what drugs the patient is taking, is essential information. A lymph node biopsy interpreted without knowledge of the patient’s medication list can easily be misread as cancer, leading to treatments that do more harm than good.
When Drug-Induced Swelling Can Become Dangerous on Its Own
Most drug-related lymphadenopathy resolves once the offending medication is discontinued, but the reaction itself can be life-threatening before anyone figures out what is going on. DRESS carries a mortality rate estimated between 5% and 10% in the medical literature, driven primarily by organ damage to the liver, kidneys, and heart rather than by the lymph node swelling itself. The lymphadenopathy is typically a visible warning sign that a systemic process is underway, not the source of danger on its own.
The exception is when viral reactivation complicates the picture. As noted earlier, HHV-6 reactivation during DRESS was associated with worse outcomes and greater severity in controlled studies.12PubMed Central. Immunopathogenic Insights on Preferential Human Herpesvirus-6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms: A Scoping Review Case reports have documented fatal multi-organ involvement driven by herpesvirus reactivation in patients whose initial drug reaction might otherwise have been survivable. This makes monitoring for viral reactivation an important part of managing severe DRESS, even though testing for it is not yet routine in every clinical setting.
Pseudolymphoma syndrome from phenytoin, while usually benign, has its own risks if accompanied by severe hepatitis, agranulocytosis, or widespread skin damage.4Seizure. Granulomatous lymphadenopathy secondary to phenytoin therapy And the methotrexate-associated lymphoproliferative disorders that do not regress after stopping the drug may require the same intensive treatment as a conventional lymphoma. The reassurance that “it’s just a drug reaction” has limits, and those limits are exactly why these conditions require close medical follow-up rather than a wait-and-see approach at home.